AI-generated summary
The authors studied breast cancer cell lines MCF-7 and MDA-MB-231 treated with celecoxib, laser irradiation, or both, measuring cell migration and expression of E-cadherin, N-cadherin and α-SMA genes. They report that the combination significantly reduced cancer cell migration and altered gene expression linked to the epithelial-mesenchymal transition. These are laboratory cell results, and the authors state that clinical validation is still needed.
- Who or what was studied
- Breast cancer cell lines MCF-7 and MDA-MB-231 (in vitro)
- Limits stated in the abstract
- The study used cultured cell lines only and the authors state that further investigation in clinical settings is essential.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.